This is a Bullish indicator signaling MEDP's price could rise from here. Traders may explore going long the stock or buying call options. Tickeron's A.I. dvisor identified 44 similar cases where MEDP's MACD histogram became positive, and 35 of them led to successful outcomes. Odds of Success: 80%. Current price $118.57 crossed the support line at $117.33 and is trading between $122.16 resistance and $117.33 support lines. Throughout the month of 10/14/20 - 11/13/20, the price experienced a -7% Downtrend. During the week of 11/06/20 - 11/13/20, the stock fell -0.77%.
Bullish Trend Analysis The Momentum Indicator moved above the 0 level on November 04, 2020. You may want to consider a long position or call options on MEDP as a result. Tickeron A.I. detected that in 55 of 70 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for MEDP just turned positive on November 13, 2020. Looking at past instances where MEDP's MACD turned positive, the stock continued to rise, Tickeron A.I. shows that in 35 of 44 cases over the following month. The odds of a continued upward trend are 80%.
MEDP moved above its 50-day Moving Average on November 13, 2020 date and that indicates a change from a downward trend to an upward trend.
Following a +5.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where MEDP advanced for three days, in 265 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
MEDP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 203 of 265 cases where MEDP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.